Answers are grounded in this paper and cite their sources.
BRCA1 and BRCA2 genes mutations increase the risk of breast and ovarian cancer. Primary diagnosis of ovarian cancer is a complicated task due to the lack of effective screening programs, in this regard, medical and genetic counseling of patients with a family history is one of the important steps to develop an optimal strategy for the management of patients. In this article is presented an analysis of a clinical case of a patient with bilateral metachronous breast and ovarian cancer with a detected germinal mutation5382insС in the BRCA1 gene.
No takes yet. Share an insight, caveat, or question.
Lyubchenko et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: